ArticleJournal for immunotherapy of cancer2019

Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor.

Jocelyn Joseph et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.